Circulatory effects of peripheral chemoreflex inhibition at rest and exercise in hypertension

We are investigating whether specialised sensors in the body that respond to changes in blood oxygen become hyperactive in people with hypertension.

What's involved?

Participation involves two experimental visits that will last ~2 ½ hours each and be separated by ~2 weeks. To learn more about the details about each experimental visit, please read the participant information sheet (linked below).

Eligibility criteria

We are inviting participants who:

  • Have high blood pressure (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg)
  • A body mass index of <18 or >30 kg/m2 (Note: your body mass index can be calculated by dividing your weight in kilograms by your height in metres squared)

Contact details

If you have any questions or concerns about this study, please get in touch:

Dr Ana Luiza Carrari Sayegh
Postdoctoral Research Fellow
Phone: 09 373 7599, ext 81438

Dr James P. Fisher
Principal Investigator
Phone: 09 373 7599, ext 86320

Further information

This study has been reviewed and approved by Health and Disability Ethics Committee.

Protocol number [2022 FULL 12280].